Cargando…
Challenges and opportunities in biomarker-driven trials: adaptive randomization
In an era of precision medicine, as advanced technology such as molecular profiling at individual patient level has been developed and become increasingly accessible and affordable, biomarker-driven trials have been received a lot of attention and are expected to receive more attention in order to i...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577777/ https://www.ncbi.nlm.nih.gov/pubmed/36267794 http://dx.doi.org/10.21037/atm-21-6027 |